Articles tagged "Heart transplant patients"

2022 American Transplant Congress
A Novel National Program to Maximize Utilization of Lung and Heart Allografts from Donors After Brain Death (DBD) and Donors After Circulatory Death (DCD) for Transplantation
W. Hassanein, N. Dang, A. Hassanein, S. Brann, S. LaFrancesca, S. Reddy, M. Al Salihi, T. Khayal
Transmedics, Andover, MA
*Purpose: To build a national network of dedicated cardiothoracic surgical procurement and Organ Care System (OCS™) ex-vivo perfusion clinical experts to: Maximize cardiothoracic donor organ…
2022 American Transplant Congress
Combined Heart-Liver Transplantation for Failing Fontan Physiology: A Large Single Center Comparative Analysis
C. J. Rosenthal¹, D. Noguchi¹, J. A. Aboulhosn², G. S. Van Arsdell³, A. Nsair⁴, M. Ha¹, L. Reardon², G. Lluri⁴, J. P. Lin⁴, S. Saab¹, A. Baird¹, R. S. Venick¹, D. G. Farmer¹, F. M. Kaldas¹
¹Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA, ²Ahmanson/UCLA Adult Congenital Heart Disease Center, UCLA, Los Angeles, CA, ³Cardiac Surgery, UCLA, Los Angeles, CA, ⁴Cardiology, UCLA, Los Angeles, CA
*Purpose: The rate of combined heart-liver transplantation (HLT) has tripled in the last decade, and continues to rise along with the number of patients with…
2022 American Transplant Congress
Clinical Use of the SIPAT Score in a Large Heart Transplant Program
S. Kim, M. Kittleson, J. Patel, N. Patel, T. Singer-Englar, D. Chang, E. Kransdorf, A. Huynh, L. Olanisa, M. Olman, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: The Stanford Integrated Psycosocial Assessment for Transplant (SIPAT) score predicts outcome after heart transplantation (HTx). Compliance with medications and clinic visits are important leading…
2022 American Transplant Congress
Pre-Transplant Evaluation of Patients Undergoing Combined Heart-Liver Transplantation and Correlation with Explant Pathology
A. Shingina¹, J. N. Menachem¹, S. Brown¹, I. A. Ziogas², W. K. Wu³, M. J. Izzy⁴, J. Liang¹, K. Washington¹, S. Alexopoulos⁵
¹Vanderbilt University Medical Center, Nashville, TN, ²Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, ³Thoracic Surgery; Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, ⁴GI and Hepatology, Vanderbilt University Medical Center, Nashville, TN, ⁵Vanderbilt Medical Center, Nashville, TN
*Purpose: Fontan-associated liver disease (FALD) is a well-described complication of Fontan physiology. More patients with failing Fontan are being evaluated for heart transplant and evidence-based…
2022 American Transplant Congress
Renal Graft Outcomes in Simultaneous Heart-Kidney Transplantation
K. Okumura, S. Ohira, M. Kai, K. Wolf, A. L. Gass, D. Spielvogel, N. Singh, D. Glicklich, D. John, T. Diflo, S. Lansman, S. Nishida, A. Dhand
Westchester Medical Center / New York Medical College, Valhalla, NY
*Purpose: Simultaneous heart and kidney transplantation (SHKT) has increased steadily in United States Previously it was shown that SHKT is associated with benefits in overall…
2022 American Transplant Congress
Real-Time Biometric Monitoring Using Wearable Devices for Pediatric Heart Transplant Rejection and Infection Surveillance
D. Gandla¹, J. B. Edelson², E. Mukhtar¹, J. Callanan¹, H. Lad¹, H. Gao¹, J. Cornetta¹, B. Keating¹
¹Department of Surgery, Perelman School of Medicine, Philadelphia, PA, ²Children's Hospital of Philadelphia, Philadelphia, PA
*Purpose: Monitoring for acute rejection (AR) after orthotopic heart transplantation (OHTx) is primarily achieved by evaluating histological endomyocardial biopsies (EMBx). However, this procedure is limited…
2022 American Transplant Congress
National Consortium Registry Insights on Management and Outcome of Hepatitis C Viremic Heart Transplants
R. Gottlieb¹, M. Salem¹, A. Ravichandran², J. Kennedy³, J. Strope⁴, S. Lin⁵, J. Chow⁶, P. Eckman⁷, S. Desai⁸, O. Larkins¹, J. Vanzyl¹, S. Hall¹
¹Baylor Scott & White Healthcare, Dallas, TX, ²Ascension Medical Group, Indianapolis, IN, ³Inova Heart and Vascular Institute, Falls Church, VA, ⁴Medical University of South Carolina, Charleston, SC, ⁵University of Washington Medical Center, Seattle, WA, ⁶Tufts Medical Center, Boston, MA, ⁷Minneapolis Heart Institute, Minneapolis, MN, ⁸Ochsner Medical Center, New Orleans, LA
*Purpose: Multicenter US registry of clinical management of HCV NAT+ hearts.*Methods: An ongoing 8-center retrospective IRB-approved registry collected baseline characteristics, labs, management, and outcomes after…
2022 American Transplant Congress
The New Heart Allocation Policy Has Increased Listing by Exception
J. R. Golbus¹, Y. Ahn², B. K. Nallamothu¹, M. N. Walsh³, D. Zaun², A. Israni², M. Colvin¹
¹University of Michigan, Ann Arbor, MI, ²Hennepin Healthcare Research Institute, Minneapolis, MN, ³Ascension St. Vincent Heart Center, Carmel, IN
*Purpose: The new heart allocation policy (October 2018) expanded the number of listing statuses and established a national review board for exception requests in an…
2022 American Transplant Congress
De Novo Donor-Specific Antibody Development in Heart Transplant Recipients Following COVID-19 Vaccination
M. Cheng¹, O. Behbahani-Nejad¹, D. Gupta²
¹Internal Medicine, Emory University School of Medicine, Atlanta, GA, ²Internal Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA
*Purpose: To determine the incidence of de novo donor-specific antibodies (DSAs) in recipients of orthotopic heart transplants (OHT) who received an mRNA vaccine against SARS-CoV-2.*Methods:…
2022 American Transplant Congress
Long-Term Follow Up of Solid Organ Transplantation Using Hepatitis C Virus Positive Donor for Hepatitis C Virus Negative Recipients
H. Sogawa¹, I. Lee², K. Okumura³, R. Bodin⁴, D. C. Wolf⁴, B. Partiula⁴, A. Dhand⁴, M. Kai⁵, S. Ohira⁵, R. Misawa¹, G. Veillette⁶, D. John¹, S. Nishida⁷, T. Diflo⁶
¹Division of Intra-abdominal Organ Transplant, Department of Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ²Department of Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ³Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY, ⁴Department of Medicine, Westchester Medical Center/ New York Medical College, Valhalla, NY, ⁵Cardiothoracic Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, ⁶Westchester Medical Center, Valhalla, NY, ⁷Westchester Medical Center/ New York Medical College, Valhalla, NY
*Purpose: To determine the effects of transplanting an HCV + solid organ to an uninfected patient who is on the transplant waiting list. Outcomes include…